Research record

Prevalence of geographic atrophy in Nordic countries and number of patients potentially eligible for intravitreal complement inhibitor treatment: A systematic review with meta-analyses and forecasting study.

Evidence synthesis published by Acta ophthalmologica, indexed because it matched monitored longevity research terms. Inclusion in this index does not establish that an intervention is effective or safe.

Plain-language guide

Five questions to ask about this record

What this is
human-synthesis record from Acta ophthalmologica.
Why it may matter
It matched a longevity topic and may show how that evidence area is developing.
Evidence
Automated topic match 60%; this is not a medical rating.
Main limitation
One research record does not prove safety, effectiveness, or usefulness for an individual.
What changed
Source metadata was published or refreshed September 8, 2023.
Where to verify
Open the primary source below for methods, population, results, and limitations.
Published
September 8, 2023
Journal
Acta ophthalmologica
Authors
Andreas Vangsted, Benjamin S Thinggaard, Anne H K Nissen, Javad N Hajari, Oliver N Klefter, Marie Krogh Nielsen, Torben L Sørensen, Jakob Grauslund, Yousif Subhi
DOI
10.1111/aos.15768
Evidence class
human-synthesis
Record status
published
Match confidence
60%
Source feed
PubMed
Automated source synopsis

Evidence synthesis published by Acta ophthalmologica, indexed because it matched monitored longevity research terms. Inclusion in this index does not establish that an intervention is effective or safe.

Evidence snapshot

What the source actually supports

Evidence stage
Evidence synthesis
Study design
Meta-Analysis; Systematic Review; Journal Article
Evidence population
Human evidence
Participants
Not reported
Population
Not reported
Duration
Not reported
Intervention
Comparator
Not reported
Outcomes measured
Reported result
No reusable finding-level result is available in this record.

Main limitationBibliographic metadata identifies the record but does not provide enough reusable detail to summarize its population, comparison, findings, or effect size.

Safety and approvalThis index record does not establish safety, effectiveness, dose, or suitability for any person. A publication record is not a regulatory approval or treatment recommendation.

Source supportBibliographic citation metadata and controlled indexing terms only. Read the linked source for methods and results.

Evidence stage · human-synthesisThis describes the study type, not whether an intervention is safe or effective.
Lab or animalHuman studyRandomized trialEvidence synthesis
Why this record appears here · 60% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Vision ageing · 60%Source terminology contains a controlled topic term. Source terminology supplies ageing or longevity context.

Automated source check 95% · update recency 50%. These figures help sort records; they are not medical ratings.

BibTeX · RIS

vision aging
Read the original source →Export JSON